Solvias acquires Chemic Labs

By The Science Advisory Board staff writers

June 17, 2021 -- Switzerland-based contract research organization (CRO) and contract development and manufacturing organization (CDMO) Solvias announced it has inked a deal to buy Chemic Laboratories, a move it said will help it gain a stronger foothold in the U.S.

Chemic, based in Canton, MA, will expand Solvias' portfolio of integrated testing and analytical services.

Chemic's founders will join Solvias' leadership team and continue to lead operations in the U.S. They also will continue to operate Chemic's product development businesses as separate entities, according to a release.

Financial terms of the deal were not disclosed.

If you like this content, please share it with a colleague!

Related Reading

Scientist.com debuts pre-assessment program for new suppliers
Scientist.com announced the launch of the company's pre-assessment program for new suppliers.

Emmes CRO acquires Orphan Reach
Clinical Research Organization (CRO) Emmes, a portfolio company of Behrman Capital, announced it has acquired Orphan Reach, an organization specialized...

Altasciences acquires Calvert Laboratories
Altasciences announced it has acquired Calvert Laboratories, a contract research organization with operations in Pennsylvania and North Carolina.

Report finds CROs modernizing, accelerating clinical trials
Contract research organizations (CROs) are modernizing and speeding up clinical trials with 90% unifying their clinical operations, according to a new...

Science 37 launches CRO program for decentralized clinical trials
Science 37 has launched a partnership program called Science 37 Certified, which is designed to empower contract research organizations (CROs) with access,...